Spanish drugmaker Grifols SA is facing restrictions on its Canadian licence to collect blood products following the deaths of two patients who made plasma donations in the country. Health Canada, ...
Grifols is a Spanish pharmaceutical company focused on blood plasma products, with a strong market position and an attractive growth pathway. The shares have underperformed peers and yielded negative ...
Grifols is a global, Spanish-based biotech company that is a favorite for many European investors, despite the fact that the company does not pay a dividend. It's one of the more well-known Spanish ...
Reuters: Grifols expects to boost revenue and free cash flow, shares soar
BARCELONA, Feb 27 (Reuters) - Spanish drugmaker Grifols (GRLS.MC), opens new tab said on Thursday it expects its revenue, core earnings and free cash flow to grow significantly in the coming years as ...
Seeking Alpha: Grifols: Looking At The Longer-Term 2025-2027 Upside After No Sale
It's time for an update on the Medical company Grifols, S.A. (GRFS). It's been about 4 months since I last updated on the business, with that update being specific to an event where Brookfield Asset ...
Yahoo Finance UK: Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount
Recent performance context for Grifols Grifols (BME:GRF) has drawn investor attention after a mixed run, with a modest 1 day gain, a negative move over the past week and month, and a deeper decline ...
Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount